> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-2/
- Published: 2019-11-10T12:00:00.000Z
- Updated: 2026-09-14T15:52:36.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5145474

[**FDA Withdraws Haemonetics ANDA**](https://www.fdaweb.com/fda-withdraws-haemonetics-anda/)  
*Federal Register* notice: FDA withdraws approval of a Haemonetics ANDA for Anticoagulant Citrate Dextrose SolutionA, USP, in plastic bags. 11/08/2019  

[**Info Collection on Generic Drug Correspondence**](https://www.fdaweb.com/info-collection-on-generic-drug-correspondence/)  
*Federal Register* notice: FDA submits to OMB an information collection revision entitled for “Controlled Correspondence Related to Generic Drug Development OMB Control No. 0910-0797." 11/08/2019  

[**Comments Sought on Post-market Surveillance Practices**](https://www.fdaweb.com/comments-sought-on-post-market-surveillance-practices/)  
*Federal Register* notice: FDA seeks comments on a draft document that details best practices for drug safety surveillance. 11/07/2019  

[**8 FDA Info Collections Gain OMB Approval**](https://www.fdaweb.com/8-fda-info-collections-gain-omb-approval/)  
*Federal Register* notice: FDA posts a list of eight information collections that have been approved by OMB. 11/06/2019 

[**Allergenic Products Advisory Committee Needs Rep**](https://www.fdaweb.com/allergenic-products-advisory-committee-needs-rep/)  
*Federal Register* notice: FDA seeks industry organizations to participate in selecting nonvoting industry representative to serve on CBER’s Allergenic Products Advisory Committee. 11/05/2019  

[**Hep D Virus Drug Development Guide**](https://www.fdaweb.com/hep-d-virus-drug-development-guide/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Chronic Hepatitis D Virus Infection: Developing Drugs for Treatment.” 11/01/2019  

[**Draft Guide on Generic Drug User Fees**](https://www.fdaweb.com/draft-guide-on-generic-drug-user-fees/)  
*Federal Register* notice: FDA makes available a draft guidance entitled “Assessing User Fees under the Generic Drug User Fee Amendments of 2017.” 11/01/2019  

[**Panel to Review Correvio Atrial Fibrillation Drug**](https://www.fdaweb.com/panel-to-review-correvio-atrial-fibrillation-drug/)  
*Federal Register* notice: FDA has announced a 12/10 Cardiovascular and Renal Drugs Advisory Committee meeting to discuss a Correvio International NDA for its atrial fibrillation drug. 11/01/2019